Crossmark

Melanoma Immunotherapy in the Elderly

Crossref DOI link: https://doi.org/10.1007/s11912-018-0656-3

Published Online: 2018-03-02

Published Print: 2018-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Orloff, Marlana
License Information

Text and Data Mining valid from 2018-02-01
More Information

Article History

First Online: 2 March 2018

Compliance with Ethical Standards

:

: Marlana Orloff has received research funding from Bristol-Myers Squibb, and has served as a consultant and advisory board member for Bristol-Myers Squibb and Immunocore.

: This article does not contain any studies with human or animal subjects performed by any of the authors.